Similarities between Index of oncology articles and Siplizumab
Index of oncology articles and Siplizumab have 5 things in common (in Unionpedia): Graft-versus-host disease, Immunotherapy, Monoclonal antibody, Natural killer cell, T cell.
Graft-versus-host disease
Graft-versus-host disease (GvHD) is a medical complication following the receipt of transplanted tissue from a genetically different person.
Graft-versus-host disease and Index of oncology articles · Graft-versus-host disease and Siplizumab ·
Immunotherapy
Immunotherapy is the "treatment of disease by inducing, enhancing, or suppressing an immune response".
Immunotherapy and Index of oncology articles · Immunotherapy and Siplizumab ·
Monoclonal antibody
Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell.
Index of oncology articles and Monoclonal antibody · Monoclonal antibody and Siplizumab ·
Natural killer cell
Natural killer cells or NK cells are a type of cytotoxic lymphocyte critical to the innate immune system.
Index of oncology articles and Natural killer cell · Natural killer cell and Siplizumab ·
T cell
A T cell, or T lymphocyte, is a type of lymphocyte (a subtype of white blood cell) that plays a central role in cell-mediated immunity.
Index of oncology articles and T cell · Siplizumab and T cell ·
The list above answers the following questions
- What Index of oncology articles and Siplizumab have in common
- What are the similarities between Index of oncology articles and Siplizumab
Index of oncology articles and Siplizumab Comparison
Index of oncology articles has 1711 relations, while Siplizumab has 8. As they have in common 5, the Jaccard index is 0.29% = 5 / (1711 + 8).
References
This article shows the relationship between Index of oncology articles and Siplizumab. To access each article from which the information was extracted, please visit: